Boston Scientific, Inc. BSX recently received FDA approval for an expanded indication of the WaveWriter Alpha Spinal Cord Stimulator (“SCS”) Systems. With this approval, the system will be available ...
Boston Scientific Corporation has acquired the fiXate tissue band and is launching the product in the United States. The fiXate Tissue Band is a novel suturing device that is designed to enable quick ...
Boston Scientific announces the European launch of the Precision Novi™ Spinal Cord Stimulator (SCS) System at the International Neuromodulation Society in Montreal, Canada. The 16-contact primary cell ...
The FDA approved Boston Scientific’s Spectra WaveWriter Spinal Cord Stimulator System. 1. The system is the first and only FDA-approved system that simultaneously provides paresthesia-based and ...
Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...